Solid-phase compound library synthesis in drug design and development

Current Opinion in Drug Discovery and Development

Volumn 5, Issue 4, 2002, Pages 594-605

  Edwards, Paul J ^a   Morrell, Andrew I ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Compound library; Drug discovery; Lead optimization; Parallel synthesis; Solid phase organic synthesis

Indexed keywords

INDOLE DERIVATIVE;

DERIVATIZATION; DRUG DESIGN; PHASE SEPARATION; PROTEIN PROTEIN INTERACTION; REVIEW; SCREENING; SOLID PHASE EXTRACTION; SYNTHESIS; TARGET CELL; ANIMAL; COMBINATORIAL CHEMISTRY; HUMAN; METHODOLOGY; PHARMACEUTICS;

ANIMALS; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DESIGN; HUMANS; TECHNOLOGY, PHARMACEUTICAL;

EID: 0036652153     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Dolle RE: Comprehensive survey of combinatorial library synthesis: 2000. J Combinatorial Chem (2001) 3:477-517.
2. Golebiowski A, Klopfenstein SR, Portlock DE: Lead compounds discovered from libraries. Curr Opin Chem Biol (2001) 5:273-284.
3. 2A antagonist. Bioorg Med Chem Lett (2000) 10:2693-2696. This paper illustrates the use of organometallic chemistry in the construction of a library of pharmacologically relevant compounds, which in turn has yielded novel, potent and selective lead material at a GPCR.
4. Willoughby CA, Hutchins SM, Rosauer KG, Dhar MJ, Chapman KT, Chicchi GG, Sadowski S, Weinberg DH, Patel S, Malkowitz L, Di Salvo J, Pacholok SG, Cheng K: Combinatorial synthesis of 3-(amidoalkyl) and 3-(aminoalkyl)-2-arylindole derivatives: Discovery of potent ligands for a variety of G-protein coupled receptors. Bioorg Med Chem Lett (2002) 12:93-96. An interesting example of how library design based upon pharmacologically well-precedented structures can provide a rich variety of leads within a receptor superfamily. This paper also demonstrates the use of synthesis in mixtures in order to rapidly prepare large numbers of analogs.
5. Zhang H-C, McComsey DF, White KB, Addo MF, Andrade-Gordon P, Derian CK, Oksenberg D, Maryanoff BE: Thrombin receptor (PAR-1) antagonists. Solid-phase synthesis of indole-based peptide mimetics by anchoring to a secondary amide. Bioorg Med Chem Lett (2001) 11:2105-2109.
6. 2 receptors. Bioorg Med Chem (2000) 8:163-171.
7. Fenwick AE, Garnier B, Gribble AD, Ife RJ, Rawlings AD, Witherington J: Solid-phase synthesis of cyclic alkoxyketones, inhibitors of the cysteine protease cathepsin K. Bioorg Med Chem Lett (2001) 11:195-198. An example of the use of IRORI technology to allow discrete, single compounds to be synthesised using the efficient 'mix-and-split' solid-phase synthesis technique.
8. Dankwart SM, Martin RL, Chan CS, Van Wart HE, Walker KAM, Delaet NG, Robinson LA: Amino acid derived sulphonamide hydroxamates as inhibitors of procollagen C-proteinase: Solid-phase synthesis of ornithine analogues. Bioorg Med Chem Lett (2001) 11:2085-2088.
9. Gong Y, Becker M, Choi-Sledeski YM, Davis RS, Salvino JM, Chu V, Brown KD, Pauls HW: Solid-phase parallel synthesis of azarene pyrrolidinones as factor Xa inhibitors. Bioorg Med Chem Lett (2000) 10:1033-1036.
10. Heinelt U, Herok S, Matter H, Wildgoose P: Solid-phase optimisation of achiral amidinobenzyl indoles as potent and selective factor Xa inhibitors. Bioorg Med Chem Lett (2001) 11:227-230. This paper provides an interesting example of the solid-phase synthesis to rapidly optimize the pharmacokinetic profile of an existing lead.
11. Poupart M-A, Cameron DR, Chabot C, Ghiro E, Goudreau N, Goulet S, Poirier M, Tsantrizos YS: Solid-phase synthesis of peptidomimetic inhibitors for the hepatitis C virus NS3 protease. J Org Chem (2001) 66:4743-4751.
12. Sasaki S, Ehara T, Alam MR, Fujino Y, Harada N, Kimura J, Nakamura H, Maeda M: Solid-phase synthesis of a library constructed of aromatic phosphate, long alkyl chains and tryptophane components, and identification of potent dipeptide telomerase inhibitors. Bioorg Med Chem Lett (2001) 11:2581-2584.
13. Sulyok GAG, Gibson C, Goodman SL, Holzemann G, Wiesner M, Kessler H: Solid-phase synthesis of a nonpeptide RGD mimetic library: New selective αvβ3 integrin antagonists. J Med Chem (2001) 44:1938-1950.
14. Van Loevezijn A, Allen JD, Schinkel AH, Koomen G-J: Inhibition of BCRP-mediated drug efflux by fumitremorgin-type indolyl diketopiperazines. Bioorg Med Chem Lett (2001) 11:29-32.
15. Stauffer SR, Katzenellenbogen JA: Solid-phase synthesis of tetrasubstituted pyrazoles, novel ligands for the estrogen receptor. J Combinatorial Chem (2000) 2:318-329. Results suggest that certain tetrasubstituted pyrazoles have high affinity and potency as agonists and antagonists for the estrogen α-subtype receptor.
16. Jin Y, Chen X, Côté M-E, Roland A, Korba B, Mounir S, Iyer RP: Parallel solid-phase synthesis of nucleoside phosphoramidate libraries. Bioorg Med Chem Lett (2001) 11:2057-2060.
17. Brown A, Carlyle I, Clark J, Hamilton W, Gibson S, McGarry G, McEachen S, Rae D, Thom S, Walker G: Discovery and SAR of org 24598 - a selective glycine uptake inhibitor. Bioorg Med Chem Lett (2001) 11:2007-2009.
18. Nicolaou KC, Cho SY, Hughes R, Winssinger N, Smethurst C, Labischinski H, Endermann R: Solid- and solution-phase synthesis of vancomycin and vancomycin analogues with activity against vancomycin-resistant bacteria. Chem Eur J (2001) 7:3798-3823. Results suggest that vancomycin derivatives, modified on one of the sugar residues, provide highly potent antibacterial agents effective against vancomycin-resistant bacteria.
19. Boume GT, Golding SW, McGeary RP, Meutermans WDF, Jones A, Marshall GR, Alewood PF, Smythe ML: The development and application of a novel safety-catch linker for BOC-based assembly of libraries of cyclic peptides. J Org Chem (2001) 66:7706-7713. Results indicate that through development of novel solid-phase strategies, large arrays of cyclic peptides can now be accessed.
20. Larsen SD, DiPaolo BA: Traceless solid-phase synthesis of 1,2,4-triazoles using a novel amine resin. Org Lett (2001) 3:3341-3344. Results indicate that the development of a novel solid-phase linker allows access to medicinally relevant 1,2,4-triazoles where two points of diversity have been introduced.
21. Dickerson TJ, Reed NN, Janda KD: Regio-reactive resin: A platform for orthogonal loading using the polymer backbone and cross-linker. Bioorg Med Chem Lett (2001) 11:1507-1509.